AAAAAA

   
Results: 1-14 |
Results: 14
EFFECT OF BONDING VARIABLES ON DENTIN MICROLEAKAGE OF A SINGLE BOTTLEADHESIVE SYSTEM
Authors: HALVORSON R
Citation: R. Halvorson, EFFECT OF BONDING VARIABLES ON DENTIN MICROLEAKAGE OF A SINGLE BOTTLEADHESIVE SYSTEM, Journal of dental research, 77, 1998, pp. 1106-1106
EFFECT OF ADHESIVES ON THE POLYMERIZATION KINETICS OF RESIN CEMENTS VIA FTIR
Authors: HALVORSON R
Citation: R. Halvorson, EFFECT OF ADHESIVES ON THE POLYMERIZATION KINETICS OF RESIN CEMENTS VIA FTIR, Journal of dental research, 77, 1998, pp. 2485-2485
URSODIOL PROPHYLAXIS AGAINST HEPATIC COMPLICATIONS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: ESSELL JH SCHROEDER MT HARMAN GS HALVORSON R LEW V CALLANDER N SNYDER M LEWIS SK ALLERTON JP THOMPSON JM
Citation: Jh. Essell et al., URSODIOL PROPHYLAXIS AGAINST HEPATIC COMPLICATIONS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 128(12), 1998, pp. 975
EFFECT OF DRYING TECHNIQUE ON BOND STRENGTHS OF ONE BOTTLE ADHESIVES
Authors: HALVORSON R
Citation: R. Halvorson, EFFECT OF DRYING TECHNIQUE ON BOND STRENGTHS OF ONE BOTTLE ADHESIVES, Journal of dental research, 76, 1997, pp. 417-417
BUSULFAN PHARMACOKINETICS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANT (BMT) - AN ANALYSIS OF THE EFFECTS OF UROSODIOL
Authors: SCHROEDER M JASLOWSKI A THOMAS A WARREN T LEWIS S ESSELL J HARMAN G ALLERTON J WILKS S OSSWALD M HALVORSON R
Citation: M. Schroeder et al., BUSULFAN PHARMACOKINETICS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANT (BMT) - AN ANALYSIS OF THE EFFECTS OF UROSODIOL, Blood, 88(10), 1996, pp. 3762-3762
CROWN MICROLEAKAGE OF VARIOUS PERMANENT CEMENT PRODUCTS
Authors: DORUFF M HALVORSON R KECK S
Citation: M. Doruff et al., CROWN MICROLEAKAGE OF VARIOUS PERMANENT CEMENT PRODUCTS, Journal of dental research, 74, 1995, pp. 243-243
NOVEL-APPROACH TO RELAPSED ACUTE MYELOGENOUS LEUKEMIA (AML) FOLLOWINGBONE-MARROW TRANSPLANTATION (BMT)
Authors: LEWIS S HALVORSON R THOMPSON J SCHROEDER M CALLANDER N
Citation: S. Lewis et al., NOVEL-APPROACH TO RELAPSED ACUTE MYELOGENOUS LEUKEMIA (AML) FOLLOWINGBONE-MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 2247-2247
BONE-MARROW TRANSPLANTATION (BMT) IN MULTIPLE-MYELOMA (MM) WITH BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) - UNACCEPTABLE TOXICITY WITH STANDARD-DOSE IN HEAVILY PRETREATED PATIENTS
Authors: RAYBON K THOMAS A SCHROEDER M LEWIS S CHRISTMAN K WILKS S OSSWALD M ABBOTT K HALVORSON R ESSELL J ALLERTON J
Citation: K. Raybon et al., BONE-MARROW TRANSPLANTATION (BMT) IN MULTIPLE-MYELOMA (MM) WITH BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) - UNACCEPTABLE TOXICITY WITH STANDARD-DOSE IN HEAVILY PRETREATED PATIENTS, Blood, 86(10), 1995, pp. 3833-3833
BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA USING CYCLOPHOSPHAMIDE AND ANTITHYMOCYTE GLOBULIN (ATG)
Authors: SHAUGHNESSY P LEWIS S SCHROEDER M ALLERTON J WILKS S CHRISTMAN K OSSWALD M ABBOTT K HARMON G HALVORSON R SNYDER M CALLANDER N
Citation: P. Shaughnessy et al., BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA USING CYCLOPHOSPHAMIDE AND ANTITHYMOCYTE GLOBULIN (ATG), Blood, 86(10), 1995, pp. 3849-3849
A STUDY OF ULTRAVIOLET-B PHOTOPROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: OSSWALD M CALLANDER N JOHNSON M HALVORSON R
Citation: M. Osswald et al., A STUDY OF ULTRAVIOLET-B PHOTOPROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Experimental hematology, 22(8), 1994, pp. 695-695
A RANDOMIZED DOUBLE-BLIND TRIAL OF PROPHYLACTIC URSODEOXYCHOLIC ACID (UDCA) VS PLACEBO TO PREVENT VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: ESSELL J SCHROEDER M THOMPSON J HARMAN G HALVORSON R CALLANDER N
Citation: J. Essell et al., A RANDOMIZED DOUBLE-BLIND TRIAL OF PROPHYLACTIC URSODEOXYCHOLIC ACID (UDCA) VS PLACEBO TO PREVENT VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 84(10), 1994, pp. 10000250-10000250
ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) IN PATIENTS WITH CARDIAC DYSFUNCTION USING BUSULFAN AND ETOPOSIDE
Authors: BANE C HALVORSON R SCHROEDER M CALLANDER N ALLERTON J SNYDER M WILKS S CHRISTMAN K LEWIS S HARMAN G
Citation: C. Bane et al., ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) IN PATIENTS WITH CARDIAC DYSFUNCTION USING BUSULFAN AND ETOPOSIDE, Blood, 84(10), 1994, pp. 10000704-10000704
DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV)PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: SCHROEDER M ESSELL J HARMAN G HALVORSON R DOLAN M CALLANDER N SNYDER M WILKS S ALLERTON J THOMPSON J
Citation: M. Schroeder et al., DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV)PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 82(10), 1993, pp. 10000425-10000425
DISTURBANCES OF COAGULATION-FACTORS WITH BONE-MARROW TRANSPLANTATION (BMT) - A POSSIBLE LINK TO THE GENESIS OF VENOOCCLUSIVE DISEASE OF THELIVER (VOD)
Authors: WILKS S ESSELL J MCGLASSON D HARMAN G HALVORSON R CALLANDER N SNYDER M ALLERTON J
Citation: S. Wilks et al., DISTURBANCES OF COAGULATION-FACTORS WITH BONE-MARROW TRANSPLANTATION (BMT) - A POSSIBLE LINK TO THE GENESIS OF VENOOCCLUSIVE DISEASE OF THELIVER (VOD), Blood, 82(10), 1993, pp. 10000623-10000623
Risultati: 1-14 |